Critical biochemical markers and ultrasound can be used to provide risk assessment for fetal anomalies. Accurate risk determination depends upon marker values being managed against variable factors like gestational age. PRISCA software* manages MoMs, correction factors, and algorithms for prenatal screening in an easy-to-use Windows® environment.
Increases in the number of diagnostic tests have improved the effectiveness of risk assessments in maternal screening programs for fetal anomolies. PRISCA software provides the necessary mathematical algorithms for risk calculation and enables you to consolidate the multiple data requirements of prenatal risk assessment without adversely affecting patient safety.
*Not available for sale in the U.S.